SE401183B - Forfarande for framstellning av (10,11-dihydro-dibenso-(b,f)-oxepin-10-yl)-piperazinderivat - Google Patents

Forfarande for framstellning av (10,11-dihydro-dibenso-(b,f)-oxepin-10-yl)-piperazinderivat

Info

Publication number
SE401183B
SE401183B SE7400553A SE7400553A SE401183B SE 401183 B SE401183 B SE 401183B SE 7400553 A SE7400553 A SE 7400553A SE 7400553 A SE7400553 A SE 7400553A SE 401183 B SE401183 B SE 401183B
Authority
SE
Sweden
Prior art keywords
dibenso
oxepin
dihydro
preparing
procedure
Prior art date
Application number
SE7400553A
Other languages
English (en)
Other versions
SE7400553L (sv
Inventor
M Gerecke
E Kyburz
J-P Kaplan
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to SE7400553A priority Critical patent/SE401183B/sv
Publication of SE7400553L publication Critical patent/SE7400553L/xx
Publication of SE401183B publication Critical patent/SE401183B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02Seven-membered rings
    • C07D313/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/14[b,f]-condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
SE7400553A 1974-01-16 1974-01-16 Forfarande for framstellning av (10,11-dihydro-dibenso-(b,f)-oxepin-10-yl)-piperazinderivat SE401183B (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE7400553A SE401183B (sv) 1974-01-16 1974-01-16 Forfarande for framstellning av (10,11-dihydro-dibenso-(b,f)-oxepin-10-yl)-piperazinderivat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7400553A SE401183B (sv) 1974-01-16 1974-01-16 Forfarande for framstellning av (10,11-dihydro-dibenso-(b,f)-oxepin-10-yl)-piperazinderivat

Publications (2)

Publication Number Publication Date
SE7400553L SE7400553L (sv) 1975-07-17
SE401183B true SE401183B (sv) 1978-04-24

Family

ID=20319929

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7400553A SE401183B (sv) 1974-01-16 1974-01-16 Forfarande for framstellning av (10,11-dihydro-dibenso-(b,f)-oxepin-10-yl)-piperazinderivat

Country Status (1)

Country Link
SE (1) SE401183B (sv)

Also Published As

Publication number Publication date
SE7400553L (sv) 1975-07-17

Similar Documents

Publication Publication Date Title
SE405601B (sv) Forfarande for framstellning av 1-(3-(naft-1-yl-oxi)-2-hydroxipropyl)-piperazinderivat
SE428562B (sv) Forfarande for framstellning av purinderivat
AR210990A1 (es) Procedimiento para preparar derivados de 1,1-dihideoperflujoroalcobenzamidas n-pirrolidin- o piperidin- sustituidas
SE423633B (sv) Forfarande for framstellning av 4-demetoxi-daunomycin
SE420199B (sv) Forfarande for framstellning av 16-oxiderade prostansyraderivat
SE421919B (sv) Forfarande for framstellning av 2-tetrahydrofurfuryl-6,7-bensomorfaner
SE7508405L (sv) Forfarande for framstellning av polyfenyloxid.
SE7508406L (sv) Forfarande for framstellning av polyfenylenoxid.
SE435713B (sv) Forfarande for framstellning av 1,3-bensoxazoler
SE431652B (sv) Forfarande for framstellning av 7beta-amino-3cefem-3ol-4-karboxylsyraderivat
SE412066B (sv) Forfarande for framstellning av famakologiskt verksamma tienodiazinderivat
SE431211B (sv) Forfarande for framstellning av n-acylamino-alfa-arylacetamido-cefalosporiner
SE7508074L (sv) Forfarande for framstellning av stilbenderivat.
SE421612B (sv) Forfarande for framstellning av alfa-6-deoxi-5-hydroxitetracyklin
SE422052B (sv) Forfarande for framstellning av vissa angivna 1-fenoxi-2-hydroxi-3-aminofenyl-propylderivat
SE418292B (sv) Forfarande for framstellning av 5-aryl-2-furamidiner
NL7514322A (nl) Kanamycinederivaten en werkwijze ter bereiding daarvan.
SE429237B (sv) Forfarande for framstellning av 9,3",4"-tri-alkanoyl sf-837 m,-derivat
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
SE425739B (sv) Forfarande for framstellning av vissa angivna tetrazolyl-bensopyranopyridinderivat
SE400960B (sv) Forfarande for framstellning av alhŸ3 (poŸ4)Ÿ2 3hŸ2o
SE414926B (sv) Forfarande for framstellning av 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler
SE415658B (sv) Analogiforfarande for framstellning av linnolinderivat
SE404364B (sv) Forfarande for framstellning av vissa angivna 5-sulfonylfenyl-tetrazolderivat
SE425784B (sv) Analogiforfarande for framstellning av eburnameninderivat